Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction.
暂无分享,去创建一个
Y. Taniyama | M. Hori | T. Masuyama | S. Takiuchi | K. Iwakura | H. Ito | Y. Higashino | K. Fujii | T. Minamino | N. Nishikawa
[1] Y. Taniyama,et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. , 1996, Circulation.
[2] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.
[3] M. Hori,et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.
[4] M. Hori,et al. Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. , 1995, Circulation.
[5] D. Baim,et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. , 1994, Circulation.
[6] S. Kaul,et al. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. , 1994, Circulation.
[7] A. Kitabatake,et al. Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.
[8] J. Shani,et al. Early and late angiographic findings of the "no-reflow" phenomenon following direct angioplasty as primary treatment for acute myocardial infarction. , 1992, American heart journal.
[9] D. Baim,et al. Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. , 1991, Catheterization and cardiovascular diagnosis.
[10] R. Kloner,et al. Experimental infarct size reduction with calcium channel blockers. , 1991, Journal of the American College of Cardiology.
[11] J. Calvin,et al. Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heart. , 1991, Journal of the American College of Cardiology.
[12] L. Becker,et al. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. , 1990, Journal of the American College of Cardiology.
[13] R. Virmani,et al. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. , 1989, Circulation.
[14] C. White,et al. INTENSE MICROVASCULAR CONSTRICTION AFTER ANGIOPLASTY OF ACUTE THROMBOTIC CORONARY ARTERIAL LESIONS , 1989, The Lancet.
[15] J. Bristow,et al. No reflow and extent of infarction during maximal vasodilation in the porcine heart. , 1988, Circulation.
[16] Dwight E. Peake,et al. Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase , 1988 .
[17] A. Jaffe,et al. Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. , 1988, Journal of the American College of Cardiology.
[18] R Roberts,et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.
[19] Harold T. Dodge,et al. Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .
[20] E. Braunwald,et al. Effect of verapamil on infarct size in dogs subjected to coronary artery occlusion with transient reperfusion. , 1986, Journal of the American College of Cardiology.
[21] L. Becker,et al. Selective enhancement of function of stunned myocardium by increased flow. , 1986, Circulation.
[22] M. Cohen,et al. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. , 1986, Circulation.
[23] W. O’Neill,et al. Demonstration of the "no-reflow" phenomenon by digital coronary arteriography. , 1986, The American journal of cardiology.
[24] E. Braunwald,et al. Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. , 1983, Circulation.
[25] Y. Ikeda,et al. Inhibition of Human Platelet Functions by Verapamil , 1981, Thrombosis and Haemostasis.
[26] E. Antman,et al. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. , 1980, Annals of internal medicine.
[27] E. Antman,et al. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. , 1980, Annals of internal medicine.
[28] E. Braunwald,et al. Ultrastructural Evidence of Microvascular Damage and Myocardial Cell Injury After Coronary Artery Occlusion: Which Comes First? , 1980, Circulation.
[29] E. Braunwald,et al. Review: Observations on experimental myocardial ischaemia , 1980 .
[30] E. Braunwald,et al. Observations on experimental myocardial ischaemia. , 1980, Cardiovascular Research.
[31] N. Maclean,et al. S.L.E. AND KLINEFELTER'S SYNDROME , 1976, The Lancet.
[32] R. Kloner,et al. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.